Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  A M A Archives of Ophthalmology

• Publication date

  2004-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHOPHT.122.12.1801PMID 15596583
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of Chemokines in Angiogenesis: CXCL12/SDF‐1 and CXCR4 Interaction, a Key Regulator of Endothelial Cell Responses

  2003cited by this paper
• Fluocinolone Acetonide Intravitreal Implant in Patients with Diabetic Macular Edema: 12 Month Results

  2003cited by this paper
• Relation of diabetic macular edema to cytokines and posterior vitreous detachment.

  2003cited by this paper
• Stromal Cell–Derived Factor-1 Effects on Ex Vivo Expanded Endothelial Progenitor Cell Recruitment for Ischemic Neovascularization

  2003cited by this paper
• HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver.

  2003cited by this paper
• Intravitreal triamcinolone acetonide for exudative age related macular degeneration

  2003cited by this paper
• Stromal cell‐derived factor 1α (SDF‐1α) induces gene‐expression of early growth response‐1 (Egr‐1) and VEGF in human arterial endothelial cells and enhances VEGF induced cell proliferation

  2003cited by this paper
• Intravitreal injection of triamcinolone for diffuse diabetic macular edema.

  2003influential reference
• A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis.

  2002cited by this paper
• Intravitreal triamcinolone for refractory diabetic macular edema.

  2002influential reference
• Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood–ocular barrier breakdown

  2002cited by this paper
• Intravitreal triamcinolone acetonide for cataract surgery with iris neovascularization.

  2002cited by this paper
• Locally Administered Ocular Corticosteroids

  2002cited by this paper
• The SDF‐1‐CXCR4 Axis Stimulates VEGF Secretion and Activates Integrins but does not Affect Proliferation and Survival in Lymphohematopoietic Cells

  2001influential reference
• Mechanism of dexamethasone-mediated interleukin-8 gene suppression in cultured airway epithelial cells.

  2001cited by this paper
• Proliferation, migration, and ERK activation in human retinal endothelial cells through A(2B) adenosine receptor stimulation.

  2001cited by this paper
• Regression of Neovascular Iris Vessels by Intravitreal Injection of Crystalline Cortisone

  2001cited by this paper
• Transendothelial migration of hematopoietic progenitor cells. Role of chemotactic factors.

  2001cited by this paper
• Transendothelial Migration of Hematopoietic Progenitor Cells

  2001cited by this paper
• INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE‐RELATED MACULAR DEGENERATION

  2000cited by this paper
• Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.

  2000cited by this paper
• Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression.

  2000cited by this paper
• Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.

  1999influential reference
• Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Induce Expression of CXCR4 on Human Endothelial Cells: In Vivo Neovascularization Induced by Stromal-Derived Factor-1α

  1999cited by this paper
• Intravitreal triamcinolone and elevated intraocular pressure.

  1999cited by this paper
• Intravitreal triamcinolone and elevated intraocular pressure.

  1999cited by this paper
• Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4.

  1999cited by this paper
• Attached posterior hyaloid membrane and the pathogenesis of honeycombed cystoid macular edema in patients with diabetes.

  1999cited by this paper
• Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide.

  1999cited by this paper
• Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development

  1998cited by this paper
• The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract

  1998cited by this paper
• Fibronectin Fragments Modulate Human Retinal Capillary Cell Proliferation and Migration

  1998cited by this paper
• Chemokine Receptors in Human Endothelial Cells

  1998cited by this paper
• The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34+ Progenitors to Peripheral Blood

  1997cited by this paper
• Posterior sub-Tenon injections of repository corticosteroids in uveitis patients with cystoid macular edema.

  1995cited by this paper
• Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression.

  1994cited by this paper
• Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation.

  1992influential reference
• Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results.

  1991cited by this paper
• Insulin-like growth factor I stimulates proliferation, migration, and plasminogen activator release by human retinal pigment epithelial cells.

  1990cited by this paper
• Insulin-like growth factor-I modulates endothelial cell chemotaxis.

  1987cited by this paper
• MACULAR EDEMA FOLLOWING PANRETINAL PHOTOCOAGULATION

  1985cited by this paper
• Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.

  1985cited by this paper
• Diabetic retinopathy. Assessment of severity and progression.

  1984influential reference
• Diabetic maculopathy. A critical review highlighting diffuse macular edema.

  1983cited by this paper
• Photocoagulation treatment of proliferative diabetic retinopathy.

  1981cited by this paper
• The lack of toxicity of intravitreally administered triamcinolone acetonide.

  1981cited by this paper
• Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings.

  1978cited by this paper

• Müller cells trophism and pathology as the next therapeutic targets for retinal diseases.

  2025cites this paper
• Precision Medicine for Diabetic Retinopathy: Integrating Genetics, Biomarkers, Lifestyle, and AI

  2025cites this paper
• Physiology and pathophysiology of the retinal neuroglia.

  2025cites this paper
• The glucocorticoid receptor as a master regulator of the Müller cell response to diabetic conditions in mice

  2024cites this paper
• Feasibility demonstration of a device for vitreous liquid biopsy incidental to intravitreal injection

  2024cites this paper
• Association of SDF-1-3′ Gene A Variant with Diabetic Retinopathy in the Hungarian Population

  2024cites this paper
• Management of treatment-naïve diabetic macular edema patients: Review of real-world clinical data

  2024cites this paper
• GMFB/AKT/TGF‐β3 in Müller cells mediated early retinal degeneration in a streptozotocin‐induced rat diabetes model

  2023cites this paper
• Lens Epithelial Explants Treated with Vitreous Humor Undergo Alterations in Chromatin Landscape with Concurrent Activation of Genes Associated with Fiber Cell Differentiation and Innate Immune Response

  2023cites this paper
• Endothelial Dysfunction and Cardiovascular Risk in Obstructive Sleep Apnea: A Review Article

  2022cites this paper
• Intraocular Pressure Changes After Intravitreal Fluocinolone Acetonide Implant: Results from Four European Countries

  2022cites this paper
• Serum and vitreous vascular endothelial growth factor levels in diabetic retinopathy

  2022cites this paper
• Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration

  2021cites this paper
• Intraoperative dexamethasone intravitreal implant in diabetic macular edema patients undergoing phacoemulsification: The CataDex study

  2021cites this paper
• The Vitreous Ecosystem in Diabetic Retinopathy: Insight into the Patho-Mechanisms of Disease

  2021cites this paper
• Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex® Outcomes

  2021cites this paper
• Bone Morphogenetic Proteins and Diabetic Retinopathy

  2021cites this paper
• Intravitreal Therapy for Diabetic Macular Edema: An Update

  2021cites this paper
• Intravitreal Dexamethasone Implant in Patients Who Did Not Complete Anti-VEGF Loading Dose During the COVID-19 Pandemic: a Retrospective Observational Study

  2021cites this paper
• Changes in aqueous and vitreous inflammatory cytokine levels in diabetic macular oedema: a systematic review and meta‐analysis

  2021cites this paper
• OPTH_A_336865 4153..4162

  2021cites this paper
• Combined Intravitreal Dexamethasone Implant and Cataract Surgery in Patients with Diabetic Retinopathy: Effect on Retinal Morphology and Function

  2020cites this paper
• Intravitreal dexamethasone implant in naïve and previously treated patients with diabetic macular edema: a retrospective study.

  2020cites this paper
• Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications.

  2019cites this paper
• Expression of vascular infarction-related molecules after anti-vascular endothelium growth factor treatment for diabetic macular edema

  2019cites this paper
• CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy.

  2019cites this paper
• The role of Müller cell glucocorticoid signaling in diabetic retinopathy

  2019cites this paper
• Molecular pathobiology of Diabetic Retinopathy

  2018cites this paper
• Dipeptidyl peptidase-4 inhibitor use and risk of diabetic retinopathy: A population-based study.

  2018cites this paper
• Anti-inflammatory cytokine and angiogenic factors levels in vitreous samples of diabetic retinopathy patients

  2018cites this paper
• Proliferative Diabetic Retinopathy: An Overview of Vitreous Immune and Biomarkers

  2018cites this paper
• Management of diabetic macular edema patients in clinical practice in Spain

  2018cites this paper
• Remodeling of Retinal Architecture in Diabetic Retinopathy: Disruption of Ocular Physiology and Visual Functions by Inflammatory Gene Products and Pyroptosis

  2018cites this paper
• Mitochondrial dysfunctions, endothelial progenitor cells and diabetic retinopathy.

  2018cites this paper
• Inhibition of stromal cell-derived factor-1α/CXCR4 signaling restores the blood-retina barrier in pericyte-deficient mouse retinas.

  2018cites this paper
• The efficacy and safety of aflibercept and conbercept in diabetic macular edema

  2018cites this paper
• Management of macular edema in vitrectomized patients with diabetes

  2018cites this paper
• Neuronal degeneration and associated alterations in cytokine and protein in an experimental branch retinal venous occlusion model

  2018cites this paper
• Pathological roles of the homeostatic chemokine CXCL12.

  2018cites this paper
• Mousetap, a Novel Technique to Collect Uncontaminated Vitreous or Aqueous and Expand Usefulness of Mouse Models

  2018cites this paper
• Efficacy of intravitreal triamcinolone acetonide with thermal combination therapy versus intravitreal triamcinolone acetonide monotherapy on diffuse diabetic macular edema

  2017cites this paper
• TPL2 (Therapeutic Targeting Tumor Progression Locus-2)/ATF4 (Activating Transcription Factor-4)/SDF1&agr; (Chemokine Stromal Cell-Derived Factor-&agr;) Axis Suppresses Diabetic Retinopathy

  2017cites this paper
• Müller cells and diabetic retinopathy

  2017cites this paper
• Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema

  2017cites this paper
• Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy

  2017cites this paper
• Considerations for management of patients with diabetic macular edema: Optimizing treatment outcomes and minimizing safety concerns through interdisciplinary collaboration.

  2017cites this paper
• [Retinal vein occlusions].

  2017cites this paper
• The Diabetic Retina: Anatomy and Pathophysiology

  2017cites this paper
• A game changer for eye care for diabetes

  2017cites this paper
• The effect of intravitreal vascular endothelial growth factor on inner retinal oxygen delivery and metabolism in rats.

  2016cites this paper
• The role of N‐glycosylation in high glucose‐induced upregulation of intercellular adhesion molecule‐1 on bovine retinal endothelial cells

  2016cites this paper
• Efficacy of single-dose dexamethasone implantation in patients with persistent diabetic macular edema

  2016cites this paper
• Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population

  2016cites this paper
• BIOCHEMICAL BASIS AND EMERGING MOLECULAR TARGETS TO TREAT DIABETIC RETINOPATHY

  2016cites this paper
• Retinal fibrosis in diabetic retinopathy.

  2016cites this paper
• Intravitreal bevacizumab plus macular laser photocoagulation for treatment of diabetic macular edema

  2016cites this paper
• Predicted molecular signaling guiding photoreceptor cell migration following transplantation into damaged retina

  2016cites this paper
• Diabetic macular oedema: pathophysiology, management challenges and treatment resistance

  2016cites this paper
• Aging Disorders of the Eye: Challenges and Approaches for Their Treatment

  2016cites this paper
• The Effect of Intravitreal Bevacizumab Injection before Panretinal Photocoagulation in Patients with Clinically Significant Macular Edema

  2015cites this paper
• The Efficiency of Intravitreal Dexamethasone Implants in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion

  2015cites this paper
• Diabetische Makulopathie

  2015cites this paper
• Ocular complications of diabetes mellitus.

  2015cites this paper
• Characterizing Migratory Signaling Pathways Of Transplantable Retinal Progenitor Cells And Photoreceptor Precursor Cells Toward Restoration Of Degenerative Retina ' A Systems Biology Approach

  2015cites this paper
• Occlusions veineuses rétiniennes

  2015cites this paper
• The effect of combined treatment of bevacizumab and triamcinolone for diabetic macular edema refractory to previous intravitreal mono-injections

  2015cites this paper
• Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment

  2014cites this paper
• Vascular endothelial growth factor modulates the function of the retinal pigment epithelium in vivo.

  2014cites this paper
• Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema.

  2014cites this paper
• Effect of glucocorticoids on neuronal and vascular pathology in a transgenic model of selective Müller cell ablation

  2014cites this paper
• Pathophysiology of Diabetic Retinopathy

  2013cites this paper
• Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions.

  2013cites this paper
• Structural and Functional Assessment of Macula in Patients with High-Risk Proliferative Diabetic Retinopathy Submitted to Panretinal Photocoagulation and Associated Intravitreal Bevacizumab Injections: A Comparative, Randomised, Controlled Trial

  2013cites this paper
• Angiogenic Factors and Cytokines in Diabetic Retinopathy.

  2013influential citation
• Dexamethasone implants in retinal vein occlusion: 12-month clinical effectiveness using repeat injections as-needed

  2013cites this paper
• Overexpression of Hemopexin in the Diabetic Eye

  2013cites this paper
• A stem cell based approach for vascular repair in diabetic retinopathy

  2012cites this paper
• Diabetic Retinopathy and Inflammation: Novel Therapeutic Targets

  2012cites this paper
• Nonsurgical Options for the Treatment of Diabetic Macular Edema

  2012cites this paper
• Aqueous concentrations of VEGF and soluble VEGF receptor-1 in diabetic retinopathy patients

  2012cites this paper
• Ангиогенез и васкулогенез при сахарном диабете: новые концепции патогенеза и лечения сосудистых осложнений

  2012cites this paper
• Concise Review: The Potential of Stromal Cell‐Derived Factor 1 and Its Receptors to Promote Stem Cell Functions in Spinal Cord Repair

  2012cites this paper
• Novel Targets Against Retinal Angiogenesis in Diabetic Retinopathy

  2012cites this paper
• Retinopathy in diabetes.

  2012cites this paper
• Effect of Triamcinolone on Retinal Vessel-Related Factors in Oxygen-Induced Retinopathy Rats

  2012cites this paper
• Cellular and Molecular Mechanism of Diabetic Retinopathy

  2012cites this paper
• New developments in the treatment of diabetic macular edema: latest clinical evidence

  2012cites this paper
• Diabetic retinopathy: current and new treatment options.

  2012cites this paper
• Dysfunction of Circulating Endothelial Progenitor Cells in Diabetic Retinopathy

  2012cites this paper
• Vasculogenesis and angiogenesis in diabetes mellitus: novel pathogenetic concepts for treatment of vascular complications

  2012cites this paper
• Proteomic analysis of ophthalmic disease

  2012cites this paper
• Targeting Atypical Protein Kinase C Isoforms for the Prevention of Blood-Retinal Barrier Dysfunction in Ophthalmic Disease

  2012cites this paper
• Detection and characterization of retinal disruption in mice using high angular resolution diffusion microscopy (HARDM)

  2012cites this paper
• EARLY CHANGE OF CENTRAL MACULAR THICKNESS AFTER INTRAVITREOUS TRIAMCINOLONE OR BEVACIZUMAB IN DIABETIC MACULAR EDEMA OR RETINAL VEIN OCCLUSION

  2011cites this paper
• Evaluación terapéutica del Bevacizumab, Intravítreo, en el tratamiento del Edema macular diabético difuso

  2011cites this paper
• Intravitreal Triamcinolone Injection as an Adjuvant to Standard Laser Therapy in Management of Proliferative Diabetic Retinopathy

  2011cites this paper
• Validation of Molecular and Genomic Biomarkers of Retinal Drug Efficacy: Use of Ocular Fluid Sampling to Evaluate VEGF

  2011cites this paper
• Effect of Focal and Grid Pattern PASCAL Photocoagulation Treatment in Diabetic Macular Edema

  2011cites this paper
• Association of Host Genetic Risk Factors with the Course of Cytomegalovirus Retinitis in Patients Infected with HIV

  2011cites this paper
• Nine‐month results of intravitreal bevacizumab versus triamcinolone for the treatment of diffuse diabetic macular oedema: a retrospective analysis

  2011cites this paper